All lobbying filings

CGCN GROUP, LLC

CGCN GROUP, LLC filed a Q2 report for FRESENIUS KABI USA, LLC on July 19, 2026, reporting $50,000 in lobbying income.

Lobbying for FRESENIUS KABI USA, LLC · Healthcare company

All filings by CGCN GROUP, LLC · Everything FRESENIUS KABI USA, LLC has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 19, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

Illinois

Official filing document

Lobbyists on this filing 2

SARAH GILBERT New on this filing

Previously held: (4) Intern, Rep. George Holding, Aug. 2016-Dec 2016; Intern, Sen. Richard Burr, June 2016-July 2016
KELLY CHILDRESS LANGE New on this filing

Previously held: Health Legislative Assistant, Rep. John Shimkus, 2001-2003 Health Policy Advisor, Rep. Mike Rogers, 2005-2008

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 4

Manufacturing

Buy America legislation, tariffs, and tax incentives.

Tariff (miscellaneous tariff bills)

Section 232 investigation into pharmaceuticals and unfair trade practices.

Taxation/Internal Revenue Code

U.S. manufacturing incentives.

Trade (domestic/foreign)

Sec. 232 investigation on pharmaceutical sector, tariffs, Buy America policies, Most Favored Nations Executive Order, reciprocal tariffs, essential medicines drug shortages related to trade agreements.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.